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Abstract 
Practical relevance: There has been increasing identification of vector-borne pathogens in 
cats presented to veterinary clinics around the world for evaluation of fever and the 
associated secondary effects like signs of depression and loss of appetite.   
Aim: The aim of this report is to summarize the clinically relevant information concerning 
fever in cats that is associated with pathogens vectored by ticks or sand flies, with an 
emphasis on presenting clinical abnormalities and optimal diagnostic, treatment and 
prevention strategies. 
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Introduction 
 In Part 1 of this two-part article series, the 2 major differentials for elevated body 
temperatures (>39.2°C, 102°F) in cats – hyperthermia and fever (pyrexia) – were reviewed 
and the infectious disease agents proven or likely to be vectored by fleas were 
summarized.1 In Part 2, the infectious disease agents vectored by ticks or sand flies are 
discussed.  Emphasis is placed on common clinical and laboratory findings, optimal 
diagnostic tests, treatments, and strategies for prevention.  
 
Tick-borne agents associated with fever 
Anaplasma phagocytophilum   
Wild caught adult Ixodes scapularis in the United States are commonly positive for 
A. phagocytophilum DNA and experimentally infested cats have been shown to be 
susceptible to A. phagocytophilum infection.2, 3 Cats do not develop permanent  immunity 
to A. phagocytophilum and repeated infections have been documented in experimentally 
infested cats.4  DNA of A. phagocytophilum or antibodies against the agent have been 
detected in naturally exposed cats in most countries with Ixodes spp..513 Ixodes spp. also 
often carry B. burgdorferi and co-infections with A. phagocytophilum are likely common.12 
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Cats infected with A. phagocytophilum after infestation with I. scapularis have not 
developed clinical signs of illness.2,4 Cats living in endemic areas are commonly 
seropositive but most do not have clinical signs of disease. When illness is recognized 
fever, anorexia, and lethargy are the most common clinical abnormalities in naturally 
infected cats.4,6,9 
Cats with fever residing in Ixodes spp. endemic areas should have blood smears 
examined cytologically attempt to find morulae (Figure 1).9  Many commercial laboratories 
offer PCR assays to amplify A. phagocytophilum DNA from blood and these assays are 
more likely to be positive than serological tests in acute illness (Table 1).2  One commercial 
assay for detection of A. phagocytophilum antibodies in dog serum (SNAP 4DXPlus, 
IDEXX Laboratories) has been shown to detect these antibodies in feline sera.2 
Approximately 30% of cats with proven clinical infections induced by A. phagocytophilum 
are seronegative when first assessed serologically, but most of the proven cases evaluated 
to date have ultimately seroconverted.5 
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Figure 1. Anaplasma phagocytophilum morula (arrow) in a neutrophil of an  
  experimentally infected cat. 
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Several antibiotics have been administered to naturally infected cats with suspected 
anaplasmosis, but all cats in 2 studies became clinically normal within 24 to 48 hours after 
initiation of tetracycline or doxycycline administration and recurrence was not reported.5,6,9 
Two cats were still PCR positive 17 days and 90 days after treatment (of 21 to 30 days 
duration) while clinically normal, which suggests that treatment with tetracyclines for 21 to 
30 days may be inadequate for eliminating this pathogen from some cats.5   
Infection of cats by A. phagocytophilum should be reduced by appropriate use of an 
acaricide.  However, in one study, purchase of a topical acaricide was not associated with a 
lessened risk of having antibodies against A. phagocytophilum, or B. burgdorferi.12  In that 
study, it appeared that owners of treated, seropositive cats did not administer the acaricide 
year round.  It is also possible that owners of cats with known exposure, and possibly 
previous infections, were more likely to purchase an acaracide. 
 
Anaplasma platys 
A number of cats have been shown to be infected by A. platys.14-17 This agent is 
suspected to be tick-borne, possibly by Rhipicephalus sanguineus.  However, whether this 
agent induces fever in cats alone or as a coinfection has not been determined.  Serological 
tests have not been validated for this organism in cats.  Thus, the diagnosis currently is 
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based on detection of morulae in platelets or amplification of specific DNA by PCR assay.  
Optimal treatments are unknown for cats, but doxycycline should be effective.  Use of 
acaricides should lessen risk of exposure. 
 
Babesia spp.   
In South Africa and parts of Asia, there is a high number of Babesia spp. that infect 
cats.  In Europe, Babesia vogeli or Babesia vulpes DNA was amplified from ticks collected 
from cats and antibodies reactive to Babesia vulpes were detected in cats.13,18-20  In the 
Americas, B. vogeli, Babesia gibsoni, and mixed infections have been described in cats.21,22 
Babesia vogeli and Babesia canis are likely more prevalent in areas with high infestation 
rates for R. sanguineus.  However, whether these agents induce fever in cats alone or as a 
coinfection has not been determined.  Serological tests have not been validated for these 
agents in cats.  Thus, the diagnosis currently is based on detection of piroplasms in 
erythrocytes or amplification of specific DNA by PCR assay.  Optimal treatments are 
unknown for cats but options primarily extrapolated from canine babesiosis were reviewd.23  
Use of acaricides should lessen risk of exposure except for B. gibsoni which may be 
transmitted directly. 
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Borrelia spp. 
 Many cats exposed to Ixodes spp. in North America and parts of Europe develop 
antibodies against B. burgdorferi.  Some cats are also infected by Borrelia persica from 
infestation by Ornithodoros tholozani in some parts of the Middle East.24  Fever can be 
associated with B. burgdorferi or B. persica infections in cats.12,24,25  However, since many 
cats have exposure to Ixodes spp., it can be difficult to determine whether clinical illness is 
resulting from A. phagocytophilum or B. burgdorferi or both.12 
 Cats with fever and suspected B. persica infections should have peripheral blood 
smears evaluated for spirochetes and the infection can be confirmed by PCR assay.24  
While not approved for this use, serum from cats with fever and suspected B. burgdorferi 
infection can be screened with a commercially available kit (SNAP  4DXPlus, IDEXX 
Laboratories, Portland Maine, USA) titrated for use with dog sera.2,4  However, a positive 
B. burgdorferi antibody assay result only proves exposure, not necessarily clinical 
borreliosis.   
 Cats with fever from suspected borreliosis generally respond to administration of 
doxycycline at 5 mg/kg, PO, q12h or 10 mg/kg, PO, q24h.12,25 The effectiveness of 
different acaricides for the prevention of transmission of Borrelia spp. to cats has not been 
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compared but, based on experiences in dogs, all should be helpful in preventing borreliosis 
in cats if used appropriately.20 
 
Cytauxzoon spp. 
Cats in the United States, Brazil and Europe can be infected by Cytauxzoon 
spp..10,26-32  It is apparent that Cytauxzoon felis infections in the United States (transmitted 
by Amblyomma americanum) can be very pathogenic when compared with the Cytauxzoon 
spp. infections occurring in cats in other countries.  This may represent different species in 
different countries.33  While fatal C. felis infections are common in some regions in the 
United States, cats that survive or have subclinical infections are also common.34,35  These 
findings suggest that a wide range of clinical presentations may occur with differences 
amongst cats perhaps related to inoculation dose, pre-existing immunity, strain variations, 
or as yet unidentified variations in immune response of the cat.  A recent study showed that 
C. felis could be transmitted after between 36 and 48 hours of tick attachment, and 
ingestion of A. americanum did not induce infections.36 
In the United States, clinical infections are recognized most commonly in the 
spring, summer and fall.  Owners of cats report non-specific complaints as lethargy and 
anorexia frequently.  The infected cats have fever or hypothermia if presented in the final 
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shock phase.  Common physical examination findings that might lead to consideration of 
this agent as a differential diagnosis include unresponsive fever, pale mucous membranes, 
icterus, splenomegaly, and hepatomegaly.10,28  Discomfort, clinical evidence of central 
nervous system disease including seizures, tachypnea with or without respiratory distress, 
and sudden death on manipulation all occur in some cats.  Recently, ocular involvement of 
cytauxzoonosis has been described.37  
Cytauxzoon spp. can be seen on the erythrocytes frequently, but cytology can be 
falsely negative in the acute stages of illness. The serious clinical signs of disease relate to 
the development of shizonts in the tissues.  The syndrome can be diagnosed by cytological 
demonstration of the piroplasmas on erythrocytes, cytological demonstration of shizonts in 
spleen, liver, or bone marrow samples, or by PCR of Cytauxzoon spp. DNA in blood or 
tissue aspirates.28 
To date, clinically affected cats have shown the best response to a combination of 
azithromycin at 10 mg/kg, PO, q24h and atovaquone at 15 mg/kg, PO, q8h, with 
approximately 60% of treated cats responding.38,39  This combination is superior to 
diminazene or imidocarb protocols.40  Minimal restraint techniques should be used during 
administration of supportive care to lessen the likelihood of sudden death. 
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The poor overall treatment response in clinical cytauxzoonosis cases is a perfect 
example of why tick control can be so important.  It is always better to prevent a vector-
borne disease rather than attempt to treat it after illness has begun.  Use of acaracides 
appropriately should lessen the risk of transmission of this agent.41 One commercially 
available flea and tick collar containing flumethrin (Seresto®, Bayer Animal Health) and a 
topical product containing sarolaner (Selamectin Plus, Zoetis) were shown to block 
transmission of C. felis by A. americanum.41,42 
 
Ehrlichia spp. 
While canine ehrlichiosis is well characterized, less is known about the agents 
associated with disease in cats.  It is likely that any country that has E. canis infections in 
dogs, has E. canis infections in cats.  Naturally exposed cats in many countries have been 
shown to have Ehrlichia-like bodies or morulae in peripheral lymphocytes or monocytes, 
have had DNA consistent with E. canis amplified from the blood or tissues, or have had 
antibodies that react to E. canis morulae or peptides.10,22,43-55  There have been field cases 
that have been positive for DNA identical to E. canis at 2 genes that never seroconverted.45  
Another study in Brazil reported that cats at greater risk for R. sanguineus infestation were 
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more likely to have higher prevalence rates (9.4%) of PCR positivity for E. canis DNA.50  
In Sicily, E. canis DNA was amplified from ticks collected from some cats.54 
Fever, lethargy, and inappetence are commonly reported clinical abnormalities in 
cats with suspected ehrlichiosis and so testing may be indicated in cats showing these signs. 
Thrombocytopenia, anemia, and monocytosis appear to be the most common clinical 
laboratory findings in naturally infected cats.43,44,49,55  Almost every abnormality noted in 
dogs with clinical ehrlichiosis has been detected in cats, including monoclonal 
gammopathy.  
A validated serological assay is not currently available and some cats with E. canis-
like DNA in blood were seronegative.45 Positive serologic test results occur in both healthy 
and clinically ill cats, and so a diagnosis of clinical ehrlichiosis should not be based on 
serologic test results alone.  Ehrlichia spp. PCR and gene sequencing can be used in cats 
with suspicious clinical signs to conﬁrm infection and should be considered the tests of 
choice at this time.  However, not all cats that are PCR positive are clinically ill. 
Clinical improvement after treatment with tetracycline, doxycycline, or imidocarb 
dipropionate has been reported for most cats with suspected ehrlichiosis.43-45  Moreover, a 
positive response to treatment was a criterion for the diagnosis of ehrlichiosis for some cats. 
The current recommendation of the American College of Veterinary Internal Medicine 
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Infectious Disease Study Group (www.acvim.org) is to administer doxycycline (10 mg/kg 
PO q24h or 5 mg/kg PO q12h for 28 days). Pancytopenia can occur in cats with 
ehrlichiosis; when this occurs in dogs it may not respond to treatment.45  
This pathogen is another example of why acaricides should be used to attempt to 
avoid infection with vector-borne disease agents.  It has been shown in dogs that E. canis 
can be transmitted within 3 hours after tick attachment.55 This short transmission time 
shows the importance of using acaricides that either rapidly kill attached ticks or, 
preferably, prevent ticks from biting in the first place.  
 
Francisella tularensis 
Cats in the United States can develop fever after infection by F. tularensis.56  Cats 
are often infected by F. tularensis by carnivorism but tick-borne transmission could occur.  
Infection can be proven by culture, amplification of specific DNA by PCR assay, or rising 
antibody titers.57  Clinically ill cats should respond to doxycycline or quinolones.  Cats in 
endemic areas should be provided tick control year round and hunting behavior should be 
minimized if possible. 
 
Hepatozoon spp. 
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 A number of investigators have amplified Hepatozoon spp. DNA from cats and the 
agent has been detected in ticks collected from cats.3,30,52,59-61 In a recent report from cats in 
southern Italy, 3 different Hepatozoon spp. were detected.60  In dogs, H. americanum 
infection is induced by ingestion of the ticks or ingestion of prey species like rabbits.62   
Whether carnivorism results in infection of cats with any Hepatozoon spp. has not been 
determined.  Fever associated with Hepatozoon spp. has not been studied extensively in 
cats; however, in dogs in the United States with H. americanum infection, fever is 
common.  In one study from Israel, fever was reported as one of the potential clinical 
manifestations in cats.59  PCR assays can be used to help confirm the diagnosis but optimal 
treatment protocols for cats with hepatozoonosis are unknown.  Use of acaricides should 
lessen the potential for transmission of these agents amongst cats. 
 
Rickettsia spp. 
Rickettsia conorii and Rickettsia massiliae DNA was amplified or antibodies 
reacted to R. conorii from the blood of cats in Spain and Italy.53,63  In one study of cats in 
the USA with fever, the R. rickettsii antibody prevalence rate in cats was 6.6%, but DNA of 
the agent was not amplified from blood.64  Similar results were seen in a study of cats in St. 
Kitts, West Indies where 22 of 52 feral cats had R. rickettsii antibodies in serum but were 
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all negative for specific DNA in blood.22  These results prove that cats are sometimes 
exposed to tick-borne spotted fever group organisms but further data are needed to 
determine significance of diseases associations like fever.  Because clinical illness in cats 
has not been documented, optimal treatment is unknown.  However, based on results in 
dogs, doxycycline or a fluoroquinolone would be logical choices.  Use of acaricides should 
lessen the potential for transmission of these agents amongst cats. 
 
Sand fly borne agents associated with fever 
Leishmania spp. 
 Feline leishmaniosis has been globally reported.61,654-75  Traditionally skin lesions 
have been described as the most frequent clinical manifestation and sometimes were the 
only finding on physical examination.  However, more recently cats have been described 
that do not have cutaneous manifestations but rather have other clinical signs, and in 
general these cases appear to be associated with a worse prognosis.  Recently, a cat with 
fever that may have related to leishmaniosis was reported.76  
The diagnosis of leishmaniosis in cats, in the presence of suspected clinical signs, 
can be achieved using direct techniques like cytology, histopathology and PCR assays 
(Figure 2).  Alternately, serological techniques such as indirect fluorescent antibody assays 
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or ELISA that evaluate the immune response of the cat against Leishmania spp. can be used 
indirectly to support the diagnosis. In contrast to dogs that can have very high antibody 
levels even when subclinical carriers, low positive titer in cats can be considered highly 
suggestive of diagnosis.77 
 
 
 
Figure 2. Cytology of an arthrocentesis in a dog with polyarthritis showing 
Leishmania amastigotes in macrophages.  Courtesy of Dr. Artuno Font, 
Barcelona, Spain 
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The information about the best management of feline leishmaniosis is mostly based 
on single case reports. Long-term administration of allopurinol (10–20 mg/kg q12h or 
q24h) is usually clinically effective, but meglumine antimoniate has also been used 
successfully in a few cases. However, in the majority of cats the infection cannot be 
cleared, so the use of adequate prevention, including sand fly control, is recommended to 
reduce the number of cats infected with Leishmania in endemic areas.787,798 
   
 
Conclusions 
 
Some tick and sand fly associated pathogens can be associated with fever in cats and the 
history and concurrent clinical signs can trigger a diagnostic work-up and, ultimately, 
appropriate therapy.   
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Prevention of these infections is preferred and there is mounting evidence that consistent 
use of products that either rapidly kill vectors or, preferably, prevent vectors from biting a 
cat is desirable. 
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Table 1. Concurrent findings and diagnostic plan suggestions for feline tick or 
sand fly borne pathogens associated with fever. 
 
Pathogens  Diagnosis* Comments 
Tick associated Concurrent 
Findings 
Direct 
identification 
techniques 
Serology  
Anaplasma 
phagocytophilum 
- Lethargy 
- Lameness 
- 
Thrombocytopenia 
- Blood or joint 
fluid cytology 
- PCR assay on 
blood 
 
- Several 
techniques 
- Available in some 
laboratories 
- Canine SNAP 
4DX Plus used in 
one  
   experimental 
study 
- Morulae in 
neutrophils 
A. platys - Lethargy 
- 
Thrombocytopenia 
- Blood cytology 
- PCR assay on 
blood 
 
- Not commercially 
available 
 
- Whether canine 
serological  
   assays cross 
react with infected 
   cats is unknown 
Babesia spp. - Hemolytic anemia - Blood smear 
cytology 
- PCR assay on 
blood 
- Not commercially 
available 
- Cytology is 
likely falsely  
  negative 
frequently 
Borrelia 
burgdorferi 
- Lethargy 
- Lameness 
- PCR assay on 
skin affected? by 
tick bites 
- PCR assay on 
synovial fluid 
- Several 
techniques 
- Available in some 
laboratories 
- Canine SNAP 
4DX Plus used in 
one  
   experimental 
study 
- PCR assay on 
blood of affected 
  dogs is generally 
negative;  
  unknown in cats 
Borrelia persica - Anemia 
- 
Thrombocytopenia 
- Blood smear 
cytology 
- PCR assay on 
blood 
- Not commercially 
available 
 
 
Cytauxzoon spp. - Anemia 
- Dyspnea 
- Findings 
consistent  
  with shock 
- Blood smear 
cytology 
- PCR assay on 
blood 
- Not commercially 
available  
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Ehrlichia spp. - Anemia 
- 
Thrombocytopenia 
- Pancytopenia 
- 
Hyperglobulinemia 
- Uveitis  
- Other 
- Blood smear 
cytology 
- PCR assay on 
blood 
- Available in some 
USA laboratories 
 
- Cytology 
commonly falsely  
  negative 
- Morulae in 
mononuclear cells 
- Serum antibodies 
have been  
  falsely negative 
in some cats 
- Most clinical 
findings in dogs  
  have been 
described in cats 
Francisella 
tularensis 
- Lymphadenopathy 
 
- Cytology  
- Fluorescent 
antibody staining 
- Culture 
- PCR assay 
- Available in some 
laboratories 
- Lymph nodes, 
abscesses, airway  
  washing used for 
direct  
  identification 
techniques 
- Rising titers can 
be used to  
  confirm recent 
infection if direct  
  techniques are 
negative 
Hepatozoon spp. - Currently 
unknown 
- Blood smear 
cytology 
- PCR assay on 
blood 
- Not commercially 
available 
 
Rickettsia 
rickettsii 
R. conorii, R 
massiliae  
- Currently 
unknown 
- PCR assay on 
blood 
- Not commercially 
available 
- Rickettsia 
rickettsii is the  
  predominant 
species in the 
USA and 
  others exist in 
Europe 
Sand fly 
associated 
    
Leishmania spp. 
(mainly L. 
infantum) 
- Skin lesions 
- 
Hyperglobulinemia 
- Lymphadenopathy 
- Uveitis 
- PCR assay on 
aspirates or  
   imprints 
- Available in some 
laboratories 
- In contrast to 
dogs, even a low  
  antibody titer 
likely proves 
infection 
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- Other 
 
*The results of the direct tests (cytology, other staining techniques, culture, PCR assays) 
confirm infection when they are positive.  However, for some agents like Ehrlichia spp. 
and Hepatozoon spp. there can be a carrier phase in healthy cats and so the positive test 
results do not confirm disease induced by the agent.  The same problem is known for most 
positive antibody test results that indicate past or current infection but do not confirm 
current infection or disease.   
 
 
 
 
Suggested pull quotes  
Since many cats have exposure to Ixodes spp., it can be difficult to determine whether 
clinical illness is resulting from A. phagocytophilum or B. burgdorferi or both. 
 
The poor overall treatment response in clinical cytauxzoonosis cases is a perfect example of 
why tick control can be so important.   
